Sciclone Pharmaceut (SCLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 134,395 | 114,229 | 86,228 | 85,803 | 84,228 |
| Marketable Securities | N/A | N/A | 75 | 75 | 2,759 |
| Receivables | 41,510 | 39,363 | 40,268 | 39,771 | 38,109 |
| Inventories | 16,587 | 10,976 | 10,703 | 15,238 | 10,424 |
| Income taxes - deferred | N/A | 299 | 326 | 6 | N/A |
| TOTAL | $195,733 | $168,521 | $140,197 | $143,417 | $137,329 |
| Non-Current Assets | |||||
| PPE Net | 2,002 | 2,651 | 1,848 | 843 | 1,377 |
| Investments And Advances | 794 | 0 | 0 | 0 | 0 |
| Intangibles | 30,838 | 32,979 | 34,521 | 35,357 | 34,313 |
| Other Non-Current Assets | 12,531 | 12,468 | 5,265 | 242 | 1,052 |
| TOTAL | $46,165 | $48,098 | $41,634 | $36,442 | $36,742 |
| Total Assets | $241,898 | $216,619 | $181,831 | $179,859 | $174,071 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 1,651 | 1,445 |
| Accounts payable and accrued liabilities | 3,645 | 4,495 | 5,311 | 7,716 | 7,787 |
| Accrued Expenses | 22,796 | 32,151 | 20,536 | 20,938 | 21,427 |
| TOTAL | $26,441 | $36,820 | $26,443 | $33,220 | $30,812 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 174 | 596 | 2,915 | 0 |
| Other Non-Current Liabilities | 92 | 87 | 114 | 44 | 237 |
| TOTAL | $92 | $87 | $114 | $44 | $237 |
| Total Liabilities | $26,533 | $36,907 | $26,557 | $33,264 | $31,049 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,506 | 49,624 | 50,056 | 51,958 | 54,009 |
| Common Shares | 51 | 50 | 50 | 52 | 54 |
| Retained earnings | -87,765 | -118,494 | -135,148 | -135,960 | -134,407 |
| Other shareholders' equity | -1,520 | 2,070 | 3,264 | 4,176 | 2,988 |
| TOTAL | $215,365 | $179,712 | $155,274 | $146,595 | $143,022 |
| Total Liabilities And Equity | $241,898 | $216,619 | $181,831 | $179,859 | $174,071 |